Being that this is my first blog post with y’all, I’ll start out by introducing myself with a warm hello and…
Articles by Ines Martins, PhD
Kiva Confections, a Californian medical cannabis company, has just introduced its new chocolate bars high in cannabidiol (CBD) and…
Reactions following Rituxan (rituximab) infusions often limit its repeat use in patients with severe systemic lupus erythematosus (SLE), and the alternative B-cell-depleting agent…
New research into a microRNA that helps to produce antibodies offering long-term protection against disease takes science a step close to…
Aurinia Pharmaceuticals will host a lupus nephritis expert breakfast on Thursday, Aug. 4, from 8:00 a.m. to 9:30 a.m. in New…
Sengenics announced five new applications for its patented Immunome Protein Array platform, which has been used in recent studies to discover autoantibody biomarkers…
Kadmon announced the publication of data from preclinical studies supporting its oral drug candidate, KD025, a small molecule ROCK2 inhibitor,…
The Office of Minority Health has awarded the American College of Rheumatology’s (ACR) The Lupus Initiative (TLI) a one-year $335,000…
Novato-based Mount Tam Biotechnologies announced the U.S. Patent and Trademark Office has issued a key patent for the company’s lead systemic lupus…
The Alliance for Lupus Research (ALR), the Lupus Research Institute (LRI) and the S.L.E. Lupus Foundation have merged to…